Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial

Y. Gao; B. Weenink; M. J. van den Bent; L. Erdem-Eraslan; J. M. Kros; P. A. E. Sillevis Smitt; K. Hoang-Xuan; A. A. Brandes; M. Vos; F. Dhermain; R. Enting; G. F. Ryan; O. Chinot; M. Ben Hassel; M. E. van Linde; W. P. Mason; J. M. M. Gijtenbeek; C. Balana; A. von Deimling; Th Gorlia; R. Stupp; M. E. Hegi; B. G. Baumert; P. J. French

doi:10.1016/j.ejca.2018.02.023

Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial

Y. Gao, B. Weenink, M. J. van den Bent, L. Erdem-Eraslan, J. M. Kros, P. A. E. Sillevis Smitt, K. Hoang-Xuan, A. A. Brandes, M. Vos, F. Dhermain, R. Enting, G. F. Ryan, O. Chinot, M. Ben Hassel, M. E. van Linde, W. P. Mason, J. M. M. Gijtenbeek, C. Balana, A. von Deimling, Th GorliaR. Stupp, M. E. Hegi, B. G. Baumert, P. J. French^*

^*Corresponding author for this work

GROW - Innovative Cancer Diagnostics & Therapy

Research output: Contribution to journal › Article › Academic › peer-review

16 Citations (Web of Science)

Original language	English
Pages (from-to)	168-178
Number of pages	11
Journal	European Journal of Cancer
Volume	94
DOIs	https://doi.org/10.1016/j.ejca.2018.02.023
Publication status	Published - 1 May 2018

Keywords

Low grade glioma
Intrinsic subtype
Pilocytic astrocytoma
Gene expression profiling
Immunophenotype
BELOB
OLIGODENDROGLIAL BRAIN-TUMORS
CENTRAL-NERVOUS-SYSTEM
PHASE-III TRIAL
RANDOMIZED-TRIAL
VINCRISTINE CHEMOTHERAPY
PILOCYTIC ASTROCYTOMAS
ADJUVANT PROCARBAZINE
RADIATION-THERAPY
EORTC 22033-26033
MGMT METHYLATION

Access to Document

10.1016/j.ejca.2018.02.023

Cite this

Gao, Y., Weenink, B., van den Bent, M. J., Erdem-Eraslan, L., Kros, J. M., Smitt, P. A. E. S., Hoang-Xuan, K., Brandes, A. A., Vos, M., Dhermain, F., Enting, R., Ryan, G. F., Chinot, O., Ben Hassel, M., van Linde, M. E., Mason, W. P., Gijtenbeek, J. M. M., Balana, C., von Deimling, A., ... French, P. J. (2018). Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial. European Journal of Cancer, 94, 168-178. https://doi.org/10.1016/j.ejca.2018.02.023

Gao, Y. ; Weenink, B. ; van den Bent, M. J. ; Erdem-Eraslan, L. ; Kros, J. M. ; Smitt, P. A. E. Sillevis ; Hoang-Xuan, K. ; Brandes, A. A. ; Vos, M. ; Dhermain, F. ; Enting, R. ; Ryan, G. F. ; Chinot, O. ; Ben Hassel, M. ; van Linde, M. E. ; Mason, W. P. ; Gijtenbeek, J. M. M. ; Balana, C. ; von Deimling, A. ; Gorlia, Th ; Stupp, R. ; Hegi, M. E. ; Baumert, B. G. ; French, P. J. / Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial. In: European Journal of Cancer. 2018 ; Vol. 94. pp. 168-178.

@article{24c0b3b261f8469eae7d4f4afce8afec,

title = "Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial",

keywords = "Low grade glioma, Intrinsic subtype, Pilocytic astrocytoma, Gene expression profiling, Immunophenotype, BELOB, OLIGODENDROGLIAL BRAIN-TUMORS, CENTRAL-NERVOUS-SYSTEM, PHASE-III TRIAL, RANDOMIZED-TRIAL, VINCRISTINE CHEMOTHERAPY, PILOCYTIC ASTROCYTOMAS, ADJUVANT PROCARBAZINE, RADIATION-THERAPY, EORTC 22033-26033, MGMT METHYLATION",

author = "Y. Gao and B. Weenink and {van den Bent}, {M. J.} and L. Erdem-Eraslan and Kros, {J. M.} and Smitt, {P. A. E. Sillevis} and K. Hoang-Xuan and Brandes, {A. A.} and M. Vos and F. Dhermain and R. Enting and Ryan, {G. F.} and O. Chinot and {Ben Hassel}, M. and {van Linde}, {M. E.} and Mason, {W. P.} and Gijtenbeek, {J. M. M.} and C. Balana and {von Deimling}, A. and Th Gorlia and R. Stupp and Hegi, {M. E.} and Baumert, {B. G.} and French, {P. J.}",

year = "2018",

month = may,

day = "1",

doi = "10.1016/j.ejca.2018.02.023",

language = "English",

volume = "94",

pages = "168--178",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "ELSEVIER SCI LTD",

}

Gao, Y, Weenink, B, van den Bent, MJ, Erdem-Eraslan, L, Kros, JM, Smitt, PAES, Hoang-Xuan, K, Brandes, AA, Vos, M, Dhermain, F, Enting, R, Ryan, GF, Chinot, O, Ben Hassel, M, van Linde, ME, Mason, WP, Gijtenbeek, JMM, Balana, C, von Deimling, A, Gorlia, T, Stupp, R, Hegi, ME, Baumert, BG & French, PJ 2018, 'Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial', European Journal of Cancer, vol. 94, pp. 168-178. https://doi.org/10.1016/j.ejca.2018.02.023

Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial. / Gao, Y.; Weenink, B.; van den Bent, M. J.; Erdem-Eraslan, L.; Kros, J. M.; Smitt, P. A. E. Sillevis; Hoang-Xuan, K.; Brandes, A. A.; Vos, M.; Dhermain, F.; Enting, R.; Ryan, G. F.; Chinot, O.; Ben Hassel, M.; van Linde, M. E.; Mason, W. P.; Gijtenbeek, J. M. M.; Balana, C.; von Deimling, A.; Gorlia, Th; Stupp, R.; Hegi, M. E.; Baumert, B. G.; French, P. J.

In: European Journal of Cancer, Vol. 94, 01.05.2018, p. 168-178.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial

AU - Gao, Y.

AU - Weenink, B.

AU - van den Bent, M. J.

AU - Erdem-Eraslan, L.

AU - Kros, J. M.

AU - Smitt, P. A. E. Sillevis

AU - Hoang-Xuan, K.

AU - Brandes, A. A.

AU - Vos, M.

AU - Dhermain, F.

AU - Enting, R.

AU - Ryan, G. F.

AU - Chinot, O.

AU - Ben Hassel, M.

AU - van Linde, M. E.

AU - Mason, W. P.

AU - Gijtenbeek, J. M. M.

AU - Balana, C.

AU - von Deimling, A.

AU - Gorlia, Th

AU - Stupp, R.

AU - Hegi, M. E.

AU - Baumert, B. G.

AU - French, P. J.

PY - 2018/5/1

Y1 - 2018/5/1

KW - Low grade glioma

KW - Intrinsic subtype

KW - Pilocytic astrocytoma

KW - Gene expression profiling

KW - Immunophenotype

KW - BELOB

KW - OLIGODENDROGLIAL BRAIN-TUMORS

KW - CENTRAL-NERVOUS-SYSTEM

KW - PHASE-III TRIAL

KW - RANDOMIZED-TRIAL

KW - VINCRISTINE CHEMOTHERAPY

KW - PILOCYTIC ASTROCYTOMAS

KW - ADJUVANT PROCARBAZINE

KW - RADIATION-THERAPY

KW - EORTC 22033-26033

KW - MGMT METHYLATION

U2 - 10.1016/j.ejca.2018.02.023

DO - 10.1016/j.ejca.2018.02.023

M3 - Article

C2 - 29571083

VL - 94

SP - 168

EP - 178

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

ER -